Charles Ryhee
Stock Analyst at TD Cowen
(2.45)
# 2,487
Out of 4,996 analysts
17
Total ratings
60%
Success rate
10.62%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $75.77 | +5.58% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $760.55 | -14.27% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $160.16 | +6.14% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $8.95 | +559.22% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $153.71 | -53.16% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $8.16 | +2,203.92% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $18.42 | +57.44% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $75.77
Upside: +5.58%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $760.55
Upside: -14.27%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $160.16
Upside: +6.14%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $8.95
Upside: +559.22%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $153.71
Upside: -53.16%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $8.16
Upside: +2,203.92%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $18.42
Upside: +57.44%